Gianna Hoffman-Luca logo

Gianna Hoffman-Luca

Description

Gianna Hoffman-Luca, Ph.D., of Perceptive Xontogeny Venture Funds

Investor Profile

Gianna Hoffman-Luca has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biopharma, Biotechnology, Clinical Trials.

Stage Focus

  • Series B (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Clinical Trials
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Gianna Hoffman-Luca frequently co-invest with?

U
North America, California, United States, Oakland
Co-Investments: 1
Blue Owl
North America, New York, United States, New York
Co-Investments: 1
Bristol-Myers Squibb
North America, New York, United States, New York
Co-Investments: 1
Goldman Sachs
North America, New York, United States, New York
Co-Investments: 1
UI
North America, California, United States, Oakland
Co-Investments: 1
Moore Strategic Ventures
North America, New York, United States, New York
Co-Investments: 1
Avidity Partners
North America, Texas, United States, Dallas
Co-Investments: 1
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
Deep Track Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 1
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Gianna Hoffman-Luca?

TORL BioTherapeutics

Culver City, California, United States

TORL BioTherapeutics is a clinical-stage biopharmaceutical business.

BiopharmaBiotechnologyClinical Trials
Series BApr 10, 2024
Amount Raised: $158,000,000